Extracorporeal photoimmunotherapy-photopheresis

Frontiers in Bioscience

Volumn 14, Issue 12, 2009, Pages 4769-4777

  Dani, Theresa ^a   Knobler, Robert ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Cutaneous T cell lymphoma; GVHD; Photoimmunotherapy; Photopheresis; Review; Scleroderma; Transplant rejection

Indexed keywords

GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOTHERAPY; PUVA; REVIEW; SKIN TUMOR; SYSTEMIC SCLEROSIS; T CELL LYMPHOMA;

GRAFT REJECTION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOTHERAPY; LYMPHOMA, T-CELL; PHOTOPHERESIS; SCLERODERMA, SYSTEMIC; SKIN NEOPLASMS;

EID: 63849235843     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3566     Document Type: Article

References (89)

1. R. Edelson, C. Berger, F. Gasparro, B. Jegasothy, P. Heald, B. Wintroub, E. Vonderheid, R. Knobler, K. Wolff, G. Plewig et al.: Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy: Preliminary Results. N Engl J Med 316(6), 297-303(1987) (Pubitemid 17036377)
2. J. Bladon, P. C. Taylor: Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease. Br J haematology 107, 707-11(1999) (Pubitemid 30020139)
3. H. Greinix, B. Volc-Platzer, P. Kahls, G. Fischer, A. Rosenmayr, F. Keil, H. Hönigsmann, and R. M. Knobler: Extracorporeal photchemopherapy in the treatment of severe steroid - refractory acute graft - versus - host disease: a pilot study. Blood 96, 2426-2431(2000)
4. R. Dall' Amico, L. Murer: Extracorporeal photochemopherapy: a new therapeutic approach for allograft rejection. Transfusion and Apheresis Science 26, 197-204(2002) (Pubitemid 34497069)
5. A. D. Guyot, D. Farhi, S. Ingen-Housz-Oro, A. Bussel, N. Parquet, C. Rabian, H. Bachelez, C. Frances: Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases. Br J Dermatol 156, 553-6(2007)
6. R. Knobler, L. E. French, Y. Kim, E. Bisaccia, W. Graninger, H. Nahavandi, F. J. Strobl et al.: A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 54, 793-99(2006)
7. A. Thierry, G. Gorgun, K. B. Miller, T. F. Roberts, K. Sprague, D. P. Schenkein, F. M. Foss: Immunomodulatory effects of extracorporeal photochemopherapy in patients with extensive graft - versus - host disease. Blood 98, 1622-1625(2001)
8. R. L. Edelson, Photopheresis: a new therapeutic concept. Yale J Biol Med 62, 565-77(1989)
9. I. Christensen, P. W. Heald: Photopheresis in the 1990's. J Clin Apheresis 6, 216-20(1991)
10. A. Oliven, Y. Shechter: Extracorporeal photopheresis: a review. Blood Rev 15, 103-8(2001) (Pubitemid 32619563)
11. R. Knobler, F. Trautinger, W. Graninger et al.: Parenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 28, 580-84(1993) (Pubitemid 23104232)
12. A. Ben-Nun, H. Wekerle, I. R. Cohen: Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292, 60-1(1981) (Pubitemid 11048545)
13. J. Holoshitz, Y. Naparstek, A. Ben-Nun, I. R. Cohen: Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 219, 56-8(1983) (Pubitemid 13204148)
14. E. C. Vonderheid, M. G. Bernengo, G. Burg et al.: Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46, 95-106(2002) (Pubitemid 34073484)
15. E. D. Seaton, R. M. Szydlo, E. Kanfer, J. F. Apperley, R. Russel-Lones: Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft - versus - host disease and analysis of predictors of response. Blood 102, 1217-1223(2003) (Pubitemid 36988025)
16. F. Meloni, A. Cascina, S. Miserere, C. Perotti, P. Vitulo, A. M. Fietta: Peripheral CD4 (+) CD25 (+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39, 213-7(2007) (Pubitemid 46175985)
17. J. K. Kirklin, R. N. Brown, S. T. Huang, D. C. Naftel, S. M. Hubbard, B. K. Rayburn, D. C. McGiffin, R. B. Bourge, R. L. Benza, J. A. Tallaj, L. J. Pinderski, S. V. Pamboukian, J. F. George, M. Marques: Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 25, 283-8(2006) (Pubitemid 43290657)
18. J. H. Horina, R. R. Müllegger, S. Horn, H. Holzer, G. Halswachs, H. Kerl, P. Wolf: Photopheresis for renal allograft rejection. Lancet 346, 61(1995)
19. U. Wollina, D. Lange, A. Looks: Short-time extracorporeal photochemotherapy in the treatment of drugresistant autoimmune bullous diseases. Dermatology 198, 140-4(1999) (Pubitemid 29204596)
20. A. H. Rook, K. R. Suchin D. M. Kao, E. K. Yoo, W. H. Macey B. J. De Nardo et al: Photopheresis: clinical applications and mechanism of action. J Invest Dermatol Symp Proc 4, 85-90(1999) (Pubitemid 29491262)
21. Z. Fehervari, S. Sakaguchi: Development and function of CD 25+CD4+ regulatory T cells. Current Opinion in Immunology 16, 203-208(2004) (Pubitemid 38332029)
22. E. Biagi, I. Di Biaso, V. Leoni, G. Gaipa, V. Rossi, C. Bugarin, G. Renoldi, M. Parma, A. Balduzzi, P. Perseghin, and A. Biondi: Extracorporeal Photochemotherapy Is Accompanied by Increasing Levels of Circulating CD4+CD25+GITR+Foxp3+CD62L+ Functional Regulatory T - Cells in Patients With Graft - Versus - Host Disease. Transplantation 84(1), 31-39(2007) (Pubitemid 47094638)
23. C. L. Berger, A. L. Xu, D. Hanlon, C. Lee, J. Schechner, E. Glusac, I. Christensen, E. Snyder, V. Holloway, R. Tigelaar, R. L. Edelson: Induction of Human Tumor - loaded Dendritic Cells. Int. J. Cancer 91, 438-447(2001) (Pubitemid 32115096)
24. Yoo E. K., A. H. Rook, R. Elenitsas, F. P. Gasparro, B. R. Vowels: Apoptosis induction by ultraviolet light A and photochemotherapy in cutaneous T cell lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol 107, 235-242(1996) (Pubitemid 26254840)
25. K. R. Suchin, M. Cassin, R. Washko, G. Nahass, M. Berkson, B. Stouch, B. R. Vowels, and A. H. Rook: Extracorporeal photochemotherapy does not suppress T - or B - cell responses to novel or recall antigens. J Am Acad Dermatol 41 (6) 980-986 (1999)
26. P. Heald, A. Rook, M. Perez et al.: Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27, 427-33(1992)
27. J. A. Zic, G. P. Stricklin, J. P. Greer et al.: Long-term follow-up of patients with cutaneous T-cell lymphoma with treated with extracorporeal photochemotherapy. J Am Acad Dermatol 35, 935-45(1996) (Pubitemid 26422118)
28. H. P. Gollnick, M. Owsianowski, J. Ramaker, S. C. Chun, C. E. Orfanos: Extracorporeal photochemotherapy-a new approach for the treatment of cutaneous T-cell lymphomas. Recent Results Cancer Res 139, 409-15(1995)
29. J. A. Zic: The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther 16, 337-346(2003) (Pubitemid 38044678)
30. R. Russell-Jones: Extracorporeal photopheresis in cutaneous T-cell lymphoma: inconsistent data underline the need for randomized studies. Br J Dermatol 142, 16-21(2000) (Pubitemid 30074465)
31. H. K. Koh, B. E. Davis, T. Meola et al.: Extracorporeal photopheresis for the treatment of 34 patients with cutaneous T-cell lymphoma (CTCL). J Invest Dermatol 102, 567(1994)
32. K. E. McKenna, S. Whittaker, L. E. Rhodes, P. Taylor, J. Lloyd, S. Ibbotson, R. Russell-Jones: Evidence-based practice of photopheresis 1987-2001: a report of the British Photodermatology Group and the U. K. Skin Lymphoma Group. Br J Dermatol 154, 7-20(2006) (Pubitemid 43381314)
33. R. Knobler, C. Jantschitsch: Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma. Transfusion and Apheresis Science 28, 81-89(2003) (Pubitemid 36298594)
34. R. Knobler, M. Girardi: Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphomas. Ann NY Acad Sci 941, 123-38(2001) (Pubitemid 32928339)
35. A. V. Evans, B. P. Wood, J. J. Scarisbrick, E. A. Fraser-Andrews, S. Chinn, A. Dean, P. Watkins, S. J. Whittaker, R. Russel-Jones: Extracorporeal photopheresis in Sézary Syndrome: hematologic parameters as predictor of response. Blood 98, 1298-301(2001)
36. J. J. Scarisbrick, S. J. Whittaker, A. V. Evans, E. A. Fraser-Andrews, F. J. Child, A. Dean, R. Russel-Jones: Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 97, 624-30(2001) (Pubitemid 32113393)
37. Y. H. Kim, A. Varghese, R. T. Hoppe: Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch Dermatol 131, 1003-8(1995)
38. S. L. Gottlieb, J. T. Wolfe, F. E. Fox et al.: Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10 year experience at a single institution. J Am Acad Dermatol 35, 946-57(1996) (Pubitemid 26422119)
39. P. Tsirigotis, V. Pappa, S. Papageorgiu, V. Kapsimali, V. Giannopoulou, I. Kaitsa, K. Girkas, E. Papageorgiu, N. Stavrianeas, T. Economopoulos, J. Dervenoulas: Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome. Br J Dermatol 156, 1362-1402(2007)
40. U. Wollina, A. Looks, J. Meyer et al: Treatment of stage II cutaneous T cell lymphoma with interferon alfa 2a and extracorporeal photochemotherapy: a prospective controlled trial. J Am Acad Dermatol 44, 253-60(2001) (Pubitemid 32172187)
41. E. Bisaccia, J. Gonzalez, M. Palangio et al.: Extracorporeal photochemotherapy alone or with adjuvant treatment of cutaneous T-cell lymphoma: a 9-year retrospective study in a single institution. J Am Acad Dermatol 43, 263-71(2000) (Pubitemid 30626004)
42. L. D. Wilson, G. W. Jones, D. Kim et al.: Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 43, 54-60(2000) (Pubitemid 30439713)
43. J. D. Miller, E. D. Kirkland, D. Santo Domingo, H. Scull, B. Jekutis, M. Dallas, K. D. Cooper, E. D. Baron: Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma. Photodermatol Photoimmunol Photomed 23, 163-171(2007) (Pubitemid 47354707)
44. K. R. Suchin, A. J. Cucchiara, S. L. Gottlieb et al.: Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution. Arch Dermatol 138, 1054-1060(2002) (Pubitemid 34875609)
45. M. Oswianowski, H. Gollnick, W. Siegert et al.: Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 14, 845-48(1994)
46. H. T. Greinix, B. Volc-Platzer, W. Rabitsch et al.: Successful use of extracorporeal photochemotherapy in the treatment of severe and chronic graft-versus-host disease. Blood 92, 3098-104(1998) (Pubitemid 28492315)
47. F. J. Child, R. Ratnavel, P. Watkins et al.: Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 23, 881-87(1999) (Pubitemid 29213689)
48. K. M. Sullivan, R. P. Witherspoon, R. Storb et al.: Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72, 555-561(1998)
49. J. L. Ferrara, H. J. Deeg: Graft-versus-host disease. New Engl J Med 324, 667-674(1991)
50. E. P. Smith, I. Sniecinsky, A. C. Dagis, P. M. Parker, D. S. Snyder, A. S. Stein, A. Nademanee, M. R. O'Donnell, A. Molina, G. M. Schmidt, D. E. Stepan, N. Kapoor, J. C. Niland, S. J. Forman: Extracorporeal photochemotherapy for treatment of drug-resistant graftvs.-host disease. Biol Blood Marrow Transplant 4, 27-37(1998) (Pubitemid 128538798)
51. E. Dippel, S. Goerdt, C. E. Orfanos: Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus-host disease: observations in four patients. Dermatology 198, 370-74(1999) (Pubitemid 29335730)
52. L. E. French, T. Alcindor, M. Shapiro, K. S. McGinnis, D. J. Margolis, D. Porter, D. G. B. Leonard, A. H. Rook, F. Foss: Graft - versus - host disease. Identification of amplified clonal T cell populations in the blood of patients with chronic graft - versus - host disease: positive correlation with response to photopheresis. Bone marrow transplantation 30(8), 509-515(2002) (Pubitemid 35331717)
53. L. E. French, S. R. Lessin, K. Addya, B. Denardo, D. J. Margolis, D. G. B. Leonard, A. H. Rook: Identification of Clonal T Cells in the bood of ptients with systemic sclerosis. Positive crrelation wth response to photopheresis. Arch Dermatol 137, 1309-1313(2001) (Pubitemid 32954180)
54. R. Knobler, L. R. French, Y. Kim, E. Bisaccia, W. Graninger, H. Nahavandi, F. J. Strobl, E. Keystone, M. Mehlmauer, A. Rook, I. Braverman: A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis. J Am Acad Dermatol 54, 793-99(2006)
55. K. Krasagakis, E. Dippel, J. Ramaker et al: Management of severe scleroderma with with long-term extracorporeal photopheresis. Dermatology 196, 309-15(1998) (Pubitemid 28224811)
56. B. Cribier, T. Faradji, C. Le Coz et al.: Extracorporeal photochemotherapy in systemic sclerosis and severe morphea. Dermatology 191, 25-31(1995)
57. D. N. H. Enomoto, J. R. Mekkes, P. M. M. Bossuyt et al.: Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis). J Am Acad Dermatol 41, 915-22(1999)
58. A. H. Rook, B. Freundlich, B. V. Jegasothy et al.: Treatment of systemic sclerosis with extracorporeal photochemotherapy. Arch Dermatol 128, 337-46(1992)
59. R. Hingorani, I. H. Choi, P. Akolkar et al.: Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J Immunol 151, 5762-5769(1993) (Pubitemid 23332385)
60. C. Olive: T cell receptor usage in autoimmune disease. Immunol Cell Biol 73, 297-307(1995)
61. M. I. Perez, R. I. Edelson, L. John, L. Laroche, C. L. Berger: Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Yale J Biol Med 62, 595-609(1989) (Pubitemid 20201940)
62. R. Dall'Amico, L. Murer: Extracorporeal photochemotherapy: a new therapeutic approach for allograft rejection. Transfus Apher Sci 26, 197-204(2002) (Pubitemid 34497069)
63. R. Dall'Amico, G. Montini, L. Murer, B. Andreetta, G. Zacchello, A. Gambino, G. Feltrin, A. Caforio, V. Tursi, U. Livi: Extracorporeal photochemotherapy after cardiac transplantation: a new therapeutic approach to allograft rejection. Int J Artif Organs 23, 49-54(2000) (Pubitemid 30116415)
64. M. Barr, B. Meiser, H. Eisen et al: Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 339, 1744-51(1998) (Pubitemid 28555433)
65. M. I. Perez, R. I. Edelson, R. L. Laroche, et al.: Inhibition of anti-skin allograft immunity by infusion with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol 92, 669-76(1989)
66. R. L. Edelson, P. W. Heald, M. I. Perez, C. Berger: Extracorporeal photochemotherapy. Biol Ther Cancer Updates 4, 1-8(1994)
67. B. S. Slovis, J. E. Loyd, L. E. King Jr.: Photopheresis for chronic rejection of lung allografts. N Engl J Med 332, 962, 1995
68. C. T. Salerno, S. J. Park, N. S. Kreykes et al.: Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg 117, 1063-9(1999) (Pubitemid 29270344)
69. J. Villanueva, S. M. Bhorade, J. A. Robinson et al.: Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 5, 44-47(2000)
70. G. Andreu, A. Achkar, J. P. Couetil et al. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 14, 793-6(1995)
71. M. L. Barr, C. J. Baker, F. A. Schenkel: Prophylactic photopheresis and chronic rejection: effects on graft intimal hyperplasia in cardiac transplantation. Clin Transplant 14, 162-6(2000) (Pubitemid 30171218)
72. M. E. Billingham, N. R. B. Cary, M. E. Hammond et al: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Tranplant 9, 587-93(1990)
73. R. Dall'Amico, U. Livi, A. Milano et al.: Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection. Transplantation 60, 1-4(1995)
74. R. Dall'Amico, L. Murer, G. Montini et al.: Successful treatment of recurrent rejection in renal transplant patients with photopheresis. J Am Soc Nephrol 9, 121-7(1998) (Pubitemid 28050053)
75. G. Sunder-Plassmann, W. Druml, R. Steininger et al.: Renal allograft rejection controlled by photopheresis. Lancet 346, 506(1995)
76. J. T. Wolfe, J. E. Tomaszewski, R. A. Grossman et al.: Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apheresis 11, 36-41(1996) (Pubitemid 26137448)
77. N. Scheinfeld: Nephrogenic fibrosing dermopathy: a comprehensive review for the dermatologist. Am J Clin Dermatol 7, 237-47(2006) (Pubitemid 44231919)
78. M. Gilliet, A. Cozzio, G. Burg, F. O. Nestle: Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol 152, 531-6(2005) (Pubitemid 40547128)
79. H. Richmond, J. Zwerner, Y. Kim, D. Florentino: Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. Arch Dermatol 143, 1025-30(2007) (Pubitemid 47296079)
80. H. I. Richter, J. Krutman, G. Goerz: Extracorporeal photopheresis in therapy-refractory disseminated discoid lupus erythematosus. Hautarzt 49, 487-91(1998) (Pubitemid 28299423)
81. G. Mohla, N. Horvath, S. Stevens: Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis. J Am Acad Dermatol 40, 780-82(1999) (Pubitemid 29230372)
82. P. A. Bécherel, A. Bussel, O. Chosidow et al: Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet 351, 805(1998) (Pubitemid 28112349)
83. L. Carallini, C. Abaterusso, V. Bedogna, N. Petrica, C. Loschia and A. Lupo: Nephrogenic systemic fibrosis. G Ital Nefrol 25(1), 14-20(2008)
84. J. L. Miller, G. P. Stricklin, J. D. Fine et al: Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. Br J Dermatol 133, 467-71(1995)
85. A. H. Rook, B. V. Jegasothy, P. W. Heald et al.: Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 112, 303-5(1990) (Pubitemid 20055357)
86. H. P. M. Gollnick, M. Owsianowski, K. M. Taube, C. E. Orfanos: Unresponsive severe generalised pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 28, 122-24(1993) (Pubitemid 23019586)
87. D. T. Woodley, J. Remington, M. Chen: Autoimmunity to Type VII Collagen: Epidermolysis bullosa acquisita. Clin Rev Allergy Immunol 33, 78-84(2007)
88. J. Judvigsson, U. samuelsson, J. Ernerudh, C. Johansson, L. Steinhammar, G. Berlin: Photpheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial. Arch Dis Child 85, 149-54(2001) (Pubitemid 32701684)
89. W. Reinisch, H. Nahavandi, R. Santella, Y. Zhang, C. Gasche, G. Moser, T. Waldhör, A. Gangl, H. Vogelsang, R. Knobler: Extracorporeal photochemotherapie in patients with steroid-dependent Crohn's disease: a prospective pilot study. Aliment Pharmacol Ther 15(9), 1313-22(2001) (Pubitemid 32835537)